Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biolight Life Sciences Ltd (NASDAQ:BOLT)

--
Delayed Data
As of --
-- -- / --
Today’s Change
--
|||52-Week Range
--
--
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
--

Company Description

BioLight Life Sciences Ltd. engages in the research, development, and market of pharmaceutical products. It operates through the Ophthalmic and Cancer Diagnostics segments. The Ophthalmic segment distributes topical drugs, surgical systems, and insertable platform under the following brands: Eye-D, IOPtiMate, TeaRx, and OphRx. The Cancer Diagnostics segment provides diagnostic kit and genetic tests which may indicate risks and cancer cells through the CellDetect and BRONJ test. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.

Contact Information

BioLight Life Sciences Ltd.
Kiryat Atidim Building 3
Tel Aviv Tel Aviv 6158101
P:972732753400
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Suzana Nahum-ZilberbergChief Executive Officer
Itai Bar-NatanChief Financial Officer
Yechiel Zvi YardeniInternal Auditor
Noa AviramSecretary & Legal Counsel